Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer

Total Pancreatectomy for Primary Pancreatic Neoplasms

(2015) Werner Hartwig et al.   ANNALS OF SURGERY

Pancreatic Adenocarcinoma

(2015) Oliver Strobel et al.   ANNALS OF SURGERY

Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis

(2015) Gaurav Sharma et al.   ANNALS OF SURGICAL ONCOLOGY

Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma

(2015) Y. Murakami et al.   BRITISH JOURNAL OF SURGERY

Neoadjuvant Chemoradiotherapy and Surgery Versus Surgery Alone in Resectable Pancreatic Cancer: A Single-Center Prospective, Randomized, Controlled Trial Which Failed to Achieve Accrual Targets

(2015) Riccardo Casadei et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity

(2015) Philip R. De Reuver et al.   SURGERY

Neoadjuvant Therapy is Associated with a Reduced Lymph Node Ratio in Patients with Potentially Resectable Pancreatic Cancer

(2014) Christina L. Roland et al.   ANNALS OF SURGICAL ONCOLOGY

FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort

(2014) L. Marthey et al.   ANNALS OF SURGICAL ONCOLOGY

Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749)

(2014) Michael Tachezy et al.   BMC CANCER

Neoadjuvant chemoradiation therapy with gemcitabine/cisplatin and surgery versus immediate surgery in resectable pancreatic cancer

(2014) Henriette Golcher et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Extended pancreatectomy in pancreatic ductal adenocarcinoma: Definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS)

(2014) Werner Hartwig et al.   SURGERY

Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)

(2014) Maximilian Bockhorn et al.   SURGERY

Impact of Tumor Grade on Pancreatic Cancer Prognosis: Validation of a Novel TNMG Staging System

(2013) Matthew M. Rochefort et al.   ANNALS OF SURGICAL ONCOLOGY

Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival

(2013) Ching-Wei D. Tzeng et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Portal Vein Resection in Borderline Resectable Pancreatic Cancer: A United Kingdom Multicenter Study

(2013) Reena Ravikumar et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Multivisceral and extended resections during pancreatoduodenectomy increase morbidity and mortality

(2013) Neil H. Bhayani et al.   SURGERY

Pancreatic Ductal Adenocarcinoma

(2012) Ioannis T. Konstantinidis et al.   ANNALS OF SURGERY

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

(2012) Matthew H. G. Katz et al.   CANCER

Open-Label, Multicenter, Randomized Phase III Trial of Adjuvant Chemoradiation Plus Interferon Alfa-2b Versus Fluorouracil and Folinic Acid for Patients With Resected Pancreatic Adenocarcinoma

(2012) Jan Schmidt et al.   JOURNAL OF CLINICAL ONCOLOGY

Arterial Resection During Pancreatectomy for Pancreatic Cancer

(2011) Nathan Mollberg et al.   ANNALS OF SURGERY

Pancreatic Cancer Surgery in the New Millennium

(2011) Werner Hartwig et al.   ANNALS OF SURGERY

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

(2011) Stefan Heinrich et al.   BMC CANCER

Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent

(2011) Skye C. Mayo et al.   CANCER

A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer

(2011) Jerome Martin Laurence et al.   JOURNAL OF GASTROINTESTINAL SURGERY

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

(2011) Thierry Conroy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma

(2010) Jerome Landry et al.   JOURNAL OF SURGICAL ONCOLOGY

Uncinate process first—a novel approach for pancreatic head resection

(2010) Thilo Hackert et al.   LANGENBECKS ARCHIVES OF SURGERY

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

Total Pancreatectomy for Pancreatic Adenocarcinoma

(2009) Sushanth Reddy et al.   ANNALS OF SURGERY

Multivisceral Resection for Pancreatic Malignancies

(2009) Werner Hartwig et al.   ANNALS OF SURGERY

The “Artery First” Approach for Resection of Pancreatic Head Cancer

(2009) Jürgen Weitz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study

(2008) B. Chauffert et al.   ANNALS OF ONCOLOGY

Most Pancreatic Cancer Resections are R1 Resections

(2008) Irene Esposito et al.   ANNALS OF SURGICAL ONCOLOGY

Influence of Resection Margins and Treatment on Survival in Patients With Pancreatic Cancer

(2008) Giovanni Butturini   ARCHIVES OF SURGERY

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

(2008) Erik von Elm et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY